Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk and Intermediate-risk Prostate Cancer-Reference-Cited by-同舟云学术

Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk and Intermediate-risk Prostate Cancer

Published:2019-10-03 Issue:11 Volume:42 Page:856-861
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Iarrobino Nick A.,Gill Beant,Sutera Philip A.,Kalash Ronny,D’ Ambrosio David,Heron Dwight E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference29 articles.

1. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial;Incrocci;Lancet Oncol,2016

2. Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial;Al-Mamgani;Radiother Oncol,2010

3. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

4. Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer;Parthan;Front Oncol,2012

5. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue;Brenner;Int J Radiat Oncol Biol Phys,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right questions – A systematic review of patient reported outcome measures used in radiotherapy and proton beam therapy;Radiotherapy and Oncology;2024-02

2. Dosimetric evaluation of inclusion of proximal seminal vesicle in target volume in low-risk prostate cancer treated with stereotactic body radiotherapy;Anatolian Current Medical Journal;2023-07-28

3. Stereotactic body radiation therapy for Japanese patients with localized prostate cancer: 2-year results and predictive factors for acute genitourinary toxicities;Japanese Journal of Clinical Oncology;2021-06-14